SOHO State of the Art Updates and Next Questions: Myelofibrosis
Pettit, Kristen, Verstovsek, Srdan, Talpaz, Moshe
Published in Clinical lymphoma, myeloma and leukemia (01.04.2019)
Published in Clinical lymphoma, myeloma and leukemia (01.04.2019)
Get full text
Journal Article
The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts
Abboud, Camille, Berman, Ellin, Cohen, Adam, Cortes, Jorge, DeAngelo, Daniel, Deininger, Michael, Devine, Steven, Druker, Brian, Fathi, Amir, Jabbour, Elias, Jagasia, Madan, Kantarjian, Hagop, Khoury, Jean, Laneuville, Pierre, Larson, Richard, Lipton, Jeffrey, Moore, Joseph O., Mughal, Tariq, O’Brien, Susan, Pinilla-Ibarz, Javier, Quintas-Cardama, Alfonso, Radich, Jerald, Reddy, Vishnu, Schiffer, Charles, Shah, Neil, Shami, Paul, Silver, Richard T., Snyder, David, Stone, Richard, Talpaz, Moshe, Tefferi, Ayalew, Van Etten, Richard A., Wetzler, Meir, Abruzzese, Elisabetta, Apperley, Jane, Breccia, Massimo, Byrne, Jenny, Cervantes, Francisco, Chelysheva, Ekaterina, Clark, R. E., de Lavallade, Hugues, Dyagil, Iryna, Gambacorti-Passerini, Carlo, Goldman, John, Haznedaroglu, Ibrahim, Hjorth-Hansen, Henrik, Holyoake, Tessa, Huntly, Brian, le Coutre, Philipp, Lomaia, Elza, Mahon, Francois-Xavier, Marin-Costa, David, Martinelli, Giovanni, Mayer, Jiri, Milojkovic, Dragana, Olavarria, Eduardo, Porkka, Kimmo, Richter, Johan, Rousselot, Philippe, Saglio, Giuseppe, Saydam, Guray, Stentoft, Jesper, Turkina, Anna, Vigneri, Paolo, Zaritskey, Andrey, Aguayo, Alvaro, Ayala, Manuel, Bendit, Israel, Maria Bengio, Raquel, Best, Carlos, Bullorsky, Eduardo, Cervera, Eduardo, DeSouza, Carmino, Fanilla, Ernesto, Gomez-Almaguer, David, Hamerschlak, Nelson, Lopez, Jose, Magarinos, Alicia, Meillon, Luis, Milone, Jorge, Moiraghi, Beatriz, Pasquini, Ricardo, Pavlovsky, Carolina, Ruiz-Arguelles, Guillermo J., Spector, Nelson, Arthur, Christopher, Browett, Peter, Grigg, Andrew, Hu, Jianda, Huang, Xiao-jun, Hughes, Tim, Jiang, Qian, Jootar, Saengsuree, Kim, Dong-Wook, Malhotra, Hemant, Malhotra, Pankaj, Matsumura, Itaru, Melo, Junia, Ohnishi, Kazunori
Published in Blood (30.05.2013)
Published in Blood (30.05.2013)
Get full text
Journal Article
The Relationship between Cause of Death in Myelofibrosis and the Dynamic International Prognostic Scoring System
Garmezy, Benjamin, Boonstra, Philip S, Kandarpa, Malathi, Talpaz, Moshe
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Phase 1 study of the PI3Kδ inhibitor INCB040093 ± JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphoma
Phillips, Tycel J., Forero-Torres, Andres, Sher, Taimur, Diefenbach, Catherine S., Johnston, Patrick, Talpaz, Moshe, Pulini, Jennifer, Zhou, Li, Scherle, Peggy, Chen, Xuejun, Barr, Paul M.
Published in Blood (19.07.2018)
Published in Blood (19.07.2018)
Get full text
Journal Article
Mechanism of mutant calreticulin-mediated activation of the thrombopoietin receptor in cancers
Venkatesan, Arunkumar, Geng, Jie, Kandarpa, Malathi, Wijeyesakere, Sanjeeva Joseph, Bhide, Ashwini, Talpaz, Moshe, Pogozheva, Irina D, Raghavan, Malini
Published in The Journal of cell biology (05.07.2021)
Published in The Journal of cell biology (05.07.2021)
Get full text
Journal Article
Quantitative MRI Identifies Heterogeneous Bone Marrow Treatment Responses in a Mouse Model of Myelofibrosis
Robison, Tanner H, Solipuram, Manisha, Lee, Winston Y, Luker, Kathryn, Pettit, Kristen M., Talpaz, Moshe, Malyarenko, Dariya, Chenevert, Thomas, Ross, Brian, Luker, Gary
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth
Mody, Rajen J, Wu, Yi-Mi, Lonigro, Robert J, Cao, Xuhong, Roychowdhury, Sameek, Vats, Pankaj, Frank, Kevin M, Prensner, John R, Asangani, Irfan, Palanisamy, Nallasivam, Dillman, Jonathan R, Rabah, Raja M, Kunju, Laxmi Priya, Everett, Jessica, Raymond, Victoria M, Ning, Yu, Su, Fengyun, Wang, Rui, Stoffel, Elena M, Innis, Jeffrey W, Roberts, J. Scott, Robertson, Patricia L, Yanik, Gregory, Chamdin, Aghiad, Connelly, James A, Choi, Sung, Harris, Andrew C, Kitko, Carrie, Rao, Rama Jasty, Levine, John E, Castle, Valerie P, Hutchinson, Raymond J, Talpaz, Moshe, Robinson, Dan R, Chinnaiyan, Arul M
Published in JAMA : the journal of the American Medical Association (01.09.2015)
Published in JAMA : the journal of the American Medical Association (01.09.2015)
Get full text
Journal Article
Quantitative MRI reveals heterogeneous impacts of treatment on diseased bone marrow in a mouse model of myelofibrosis
Robison, Tanner H., Lee, Winston, Luker, Kathryn E., Pettit, Kristen, Talpaz, Moshe, Chenevert, Thomas L., Ross, Brian D., Luker, Gary D.
Published in Magnetic resonance in medicine (01.06.2024)
Published in Magnetic resonance in medicine (01.06.2024)
Get full text
Journal Article
Superior Pre-Clinical Efficacy of Novel Protac Based BET Degrader in a Large Acute Myeloid Leukemia Cohort
Kandarpa, Malathi, Peterson, Luke F., Potu, Harish, Liu, Yihong, Polk, Avery, Wang, Shaomeng, Talpaz, Moshe
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis
Mascarenhas, John, Kremyanskaya, Marina, Patriarca, Andrea, Palandri, Francesca, Devos, Timothy, Passamonti, Francesco, Rampal, Raajit K, Mead, Adam J, Hobbs, Gabriella, Scandura, Joseph M, Talpaz, Moshe, Granacher, Nikki, Somervaille, Tim C P, Hoffman, Ronald, Wondergem, Marielle J, Salama, Mohamed E, Colak, Gozde, Cui, Jike, Kiladjian, Jean-Jacques, Vannucchi, Alessandro M, Verstovsek, Srdan, Curto-García, Natalia, Harrison, Claire, Gupta, Vikas
Published in Journal of clinical oncology (10.11.2023)
Published in Journal of clinical oncology (10.11.2023)
Get full text
Journal Article
Impact of p210Bcr-Abl on Ultraviolet C Wavelength-induced DNA Damage and Repair
LAURENT, Eunice, MITCHELL, David L, ESTROV, Zeev, LOWERY, Megan, TUCKER, Susan L, TALPAZ, Moshe, KURZROCK, Razelle
Published in Clinical cancer research (01.09.2003)
Get full text
Published in Clinical cancer research (01.09.2003)
Journal Article
Efficacy and Safety of Fedratinib in Patients with Myelofibrosis Previously Treated with Ruxolitinib: Results from the Phase 3 Randomized FREEDOM2 Study
Harrison, Claire N, Mesa, Ruben, Talpaz, Moshe, Al-Ali, Haifa Kathrin, Xicoy, Blanca, Passamonti, Francesco, Palandri, Francesca, Benevolo, Giulia, Vannucchi, Alessandro M., Mediavilla, Clemence, Iurlo, Alessandra, Kim, InHo, Brown, Patrick, Hernandez, Christopher, Rose, Shelonitda, Wang, Jia, Kiladjian, Jean-Jacques
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial
Lipton, Jeffrey H, Prof, Chuah, Charles, MD, Guerci-Bresler, Agnès, MD, Rosti, Gianantonio, Prof, Simpson, David, Prof, Assouline, Sarit, MD, Etienne, Gabriel, MD, Nicolini, Franck E, MD, le Coutre, Philipp, Prof, Clark, Richard E, Prof, Stenke, Leif, MD, Andorsky, David, MD, Oehler, Vivian, MD, Lustgarten, Stephanie, PhD, Rivera, Victor M, PhD, Clackson, Timothy, PhD, Haluska, Frank G, MD, Baccarani, Michele, Prof, Cortes, Jorge E, Prof, Guilhot, François, Prof, Hochhaus, Andreas, Prof, Hughes, Timothy, Prof, Kantarjian, Hagop M, Prof, Shah, Neil P, Prof, Talpaz, Moshe, Prof, Deininger, Michael W, Prof
Published in The lancet oncology (01.05.2016)
Published in The lancet oncology (01.05.2016)
Get full text
Journal Article
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials
Jabbour, Elias, Apperley, Jane, Cortes, Jorge, Rea, Delphine, Deininger, Michael, Abruzzese, Elisabetta, Chuah, Charles, DeAngelo, Daniel J., Hochhaus, Andreas, Lipton, Jeffrey H., Mauro, Michael, Nicolini, Franck, Pinilla-Ibarz, Javier, Rosti, Gianantonio, Rousselot, Philippe, Shah, Neil P., Talpaz, Moshe, Vorog, Alexander, Ren, Xiaowei, Kantarjian, Hagop
Published in Leukemia (01.03.2024)
Published in Leukemia (01.03.2024)
Get full text
Journal Article
Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies
Peterson, Luke F., Sun, Hanshi, Liu, Yihong, Potu, Harish, Kandarpa, Malathi, Ermann, Monika, Courtney, Stephen M., Young, Matthew, Showalter, Hollis D., Sun, Duxin, Jakubowiak, Andrzej, Malek, Sami N., Talpaz, Moshe, Donato, Nicholas J.
Published in Blood (04.06.2015)
Published in Blood (04.06.2015)
Get full text
Journal Article
Efficacy of HMA +/- Venetoclax or Intensive Chemotherapy in Blast-Phase Myeloproliferative Neoplasms
Yoon, James J., Benitez, Lydia L., Bixby, Dale L., Burke, Patrick W., Marini, Bernard L., Perissinotti, Anthony J., Talpaz, Moshe, Pettit, Kristen M.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Safety and efficacy of fedratinib, a selective oral inhibitor of Janus kinase‐2 (JAK2), in patients with myelofibrosis and low pretreatment platelet counts
Harrison, Claire N., Schaap, Nicolaas, Vannucchi, Alessandro M., Kiladjian, Jean‐Jacques, Passamonti, Francesco, Zweegman, Sonja, Talpaz, Moshe, Verstovsek, Srdan, Rose, Shelonitda, Zhang, Jun, Sy, Oumar, Mesa, Ruben A.
Published in British journal of haematology (01.07.2022)
Published in British journal of haematology (01.07.2022)
Get full text
Journal Article
Ponatinib after failure of second‐generation tyrosine kinase inhibitor in resistant chronic‐phase chronic myeloid leukemia
Kantarjian, Hagop M., Jabbour, Elias, Deininger, Michael, Abruzzese, Elisabetta, Apperley, Jane, Cortes, Jorge, Chuah, Charles, DeAngelo, Daniel J., DiPersio, John, Hochhaus, Andreas, Lipton, Jeffrey, Nicolini, Franck E., Pinilla‐Ibarz, Javier, Rea, Delphine, Rosti, Gianantonio, Rousselot, Philippe, Shah, Neil P., Talpaz, Moshe, Srivastava, Shouryadeep, Ren, Xiaowei, Mauro, Michael
Published in American journal of hematology (01.11.2022)
Published in American journal of hematology (01.11.2022)
Get full text
Journal Article
Safety and Efficacy of Ruxolitinib in Patients with Myelofibrosis and Low Platelet Counts (50 – 100 × 109/L): Final Analysis of an Open-Label Phase 2 Study
Talpaz, Moshe, Prchal, Josef, Afrin, Lawrence, Arcasoy, Murat, Hamburg, Solomon, Clark, Jason, Kornacki, Deanna, Colucci, Philomena, Verstovsek, Srdan
Published in Clinical lymphoma, myeloma and leukemia (01.05.2022)
Published in Clinical lymphoma, myeloma and leukemia (01.05.2022)
Get full text
Journal Article